Wang, M., Paludo, J., Farias, J. S. D. H., Villa, D., Forsyth, C., John, E., Che, M., Arora, H., Delury, C., Otero, V., Song, Y. (2025). Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in patients with previously untreated mantle cell lymphoma: Updated analysis of the phase 3 ECHO trial after 50 months of follow-up. Blood. https://doi.org/10.1182/blood-2025-885